nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—PPARG—colon cancer	0.377	0.736	CbGaD
Telmisartan—ABCB1—colon cancer	0.135	0.264	CbGaD
Telmisartan—SLCO1B3—Methotrexate—colon cancer	0.051	0.142	CbGbCtD
Telmisartan—ABCC2—Irinotecan—colon cancer	0.0493	0.138	CbGbCtD
Telmisartan—ABCG2—Irinotecan—colon cancer	0.0446	0.125	CbGbCtD
Telmisartan—ABCC2—Vincristine—colon cancer	0.0431	0.12	CbGbCtD
Telmisartan—ABCG2—Fluorouracil—colon cancer	0.0428	0.119	CbGbCtD
Telmisartan—ABCG2—Vincristine—colon cancer	0.0389	0.109	CbGbCtD
Telmisartan—ABCC2—Methotrexate—colon cancer	0.0261	0.0729	CbGbCtD
Telmisartan—ABCG2—Methotrexate—colon cancer	0.0236	0.0659	CbGbCtD
Telmisartan—ABCB1—Irinotecan—colon cancer	0.0161	0.0449	CbGbCtD
Telmisartan—ABCB1—Vincristine—colon cancer	0.014	0.0392	CbGbCtD
Telmisartan—ABCB1—Methotrexate—colon cancer	0.0085	0.0238	CbGbCtD
Telmisartan—ABCC2—bile—colon cancer	0.00568	0.15	CbGeAlD
Telmisartan—PPARG—Topotecan—Irinotecan—colon cancer	0.00276	1	CbGdCrCtD
Telmisartan—AGTR1—endothelium—colon cancer	0.00251	0.0663	CbGeAlD
Telmisartan—AGTR1—blood vessel—colon cancer	0.00232	0.0611	CbGeAlD
Telmisartan—PPARG—endothelium—colon cancer	0.00207	0.0545	CbGeAlD
Telmisartan—PPARG—blood vessel—colon cancer	0.00191	0.0503	CbGeAlD
Telmisartan—SLCO1B3—vagina—colon cancer	0.00125	0.0329	CbGeAlD
Telmisartan—PPARG—embryo—colon cancer	0.00114	0.03	CbGeAlD
Telmisartan—AGTR1—epithelium—colon cancer	0.00113	0.0297	CbGeAlD
Telmisartan—AGTR1—smooth muscle tissue—colon cancer	0.00109	0.0287	CbGeAlD
Telmisartan—SLCO1B3—liver—colon cancer	0.00105	0.0278	CbGeAlD
Telmisartan—AGTR1—renal system—colon cancer	0.00105	0.0276	CbGeAlD
Telmisartan—PPARG—epithelium—colon cancer	0.000928	0.0245	CbGeAlD
Telmisartan—PPARG—smooth muscle tissue—colon cancer	0.000894	0.0236	CbGeAlD
Telmisartan—AGTR1—lymphoid tissue—colon cancer	0.000869	0.0229	CbGeAlD
Telmisartan—PPARG—renal system—colon cancer	0.00086	0.0227	CbGeAlD
Telmisartan—AGTR1—vagina—colon cancer	0.000758	0.02	CbGeAlD
Telmisartan—ABCC2—renal system—colon cancer	0.000756	0.0199	CbGeAlD
Telmisartan—ABCG2—Abacavir transmembrane transport—ABCB1—colon cancer	0.000733	0.0688	CbGpPWpGaD
Telmisartan—PPARG—lymphoid tissue—colon cancer	0.000714	0.0188	CbGeAlD
Telmisartan—PPARG—digestive system—colon cancer	0.000706	0.0186	CbGeAlD
Telmisartan—PPARG—bone marrow—colon cancer	0.000651	0.0172	CbGeAlD
Telmisartan—AGTR1—liver—colon cancer	0.000639	0.0169	CbGeAlD
Telmisartan—PPARG—vagina—colon cancer	0.000623	0.0164	CbGeAlD
Telmisartan—ABCC2—digestive system—colon cancer	0.00062	0.0164	CbGeAlD
Telmisartan—ABCB1—blood vessel—colon cancer	0.000602	0.0159	CbGeAlD
Telmisartan—ABCC2—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000579	0.0543	CbGpPWpGaD
Telmisartan—CYP2C19—digestive system—colon cancer	0.000533	0.0141	CbGeAlD
Telmisartan—PPARG—liver—colon cancer	0.000526	0.0139	CbGeAlD
Telmisartan—AGTR1—lymph node—colon cancer	0.00049	0.0129	CbGeAlD
Telmisartan—CYP2C19—vagina—colon cancer	0.000471	0.0124	CbGeAlD
Telmisartan—ABCC2—liver—colon cancer	0.000462	0.0122	CbGeAlD
Telmisartan—ABCG2—Abacavir transport and metabolism—ABCB1—colon cancer	0.000421	0.0395	CbGpPWpGaD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—AXIN2—colon cancer	0.00042	0.0394	CbGpPWpGaD
Telmisartan—ABCG2—bone marrow—colon cancer	0.000417	0.011	CbGeAlD
Telmisartan—PPARG—lymph node—colon cancer	0.000403	0.0106	CbGeAlD
Telmisartan—ABCG2—vagina—colon cancer	0.000399	0.0105	CbGeAlD
Telmisartan—CYP2C19—liver—colon cancer	0.000397	0.0105	CbGeAlD
Telmisartan—ABCB1—embryo—colon cancer	0.000359	0.00948	CbGeAlD
Telmisartan—ABCC2—lymph node—colon cancer	0.000354	0.00934	CbGeAlD
Telmisartan—ABCG2—liver—colon cancer	0.000337	0.00889	CbGeAlD
Telmisartan—PPARG—Nuclear Receptors—HNF4A—colon cancer	0.000318	0.0298	CbGpPWpGaD
Telmisartan—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000317	0.0297	CbGpPWpGaD
Telmisartan—ABCB1—epithelium—colon cancer	0.000293	0.00773	CbGeAlD
Telmisartan—ABCB1—renal system—colon cancer	0.000272	0.00717	CbGeAlD
Telmisartan—ABCC2—Irinotecan Pathway—APC—colon cancer	0.000267	0.025	CbGpPWpGaD
Telmisartan—ABCG2—lymph node—colon cancer	0.000258	0.00681	CbGeAlD
Telmisartan—PPARG—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.000251	0.0236	CbGpPWpGaD
Telmisartan—Candesartan—ABCB1—colon cancer	0.000236	0.608	CrCbGaD
Telmisartan—ABCG2—Irinotecan Pathway—APC—colon cancer	0.000232	0.0217	CbGpPWpGaD
Telmisartan—ABCB1—lymphoid tissue—colon cancer	0.000226	0.00596	CbGeAlD
Telmisartan—ABCB1—digestive system—colon cancer	0.000223	0.00588	CbGeAlD
Telmisartan—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000217	0.0203	CbGpPWpGaD
Telmisartan—ABCB1—bone marrow—colon cancer	0.000206	0.00542	CbGeAlD
Telmisartan—AGTR1—ACE Inhibitor Pathway—TGFB1—colon cancer	0.000201	0.0188	CbGpPWpGaD
Telmisartan—ABCB1—vagina—colon cancer	0.000197	0.00519	CbGeAlD
Telmisartan—CYP2C19—Metapathway biotransformation—CHST4—colon cancer	0.000195	0.0183	CbGpPWpGaD
Telmisartan—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000191	0.0179	CbGpPWpGaD
Telmisartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000182	0.0171	CbGpPWpGaD
Telmisartan—Myocardial infarction—Capecitabine—colon cancer	0.000176	0.00225	CcSEcCtD
Telmisartan—Oedema—Vincristine—colon cancer	0.000176	0.00225	CcSEcCtD
Telmisartan—Anaphylactic shock—Vincristine—colon cancer	0.000176	0.00225	CcSEcCtD
Telmisartan—Infection—Vincristine—colon cancer	0.000175	0.00224	CcSEcCtD
Telmisartan—Urinary tract infection—Capecitabine—colon cancer	0.000175	0.00224	CcSEcCtD
Telmisartan—Conjunctivitis—Capecitabine—colon cancer	0.000175	0.00224	CcSEcCtD
Telmisartan—Osteoarthritis—Methotrexate—colon cancer	0.000174	0.00222	CcSEcCtD
Telmisartan—ABCC2—ABC-family proteins mediated transport—ABCB1—colon cancer	0.000174	0.0163	CbGpPWpGaD
Telmisartan—Nervous system disorder—Vincristine—colon cancer	0.000173	0.00221	CcSEcCtD
Telmisartan—Thrombocytopenia—Vincristine—colon cancer	0.000172	0.0022	CcSEcCtD
Telmisartan—Haematuria—Capecitabine—colon cancer	0.000172	0.00219	CcSEcCtD
Telmisartan—Anaphylactic shock—Irinotecan—colon cancer	0.000171	0.00219	CcSEcCtD
Telmisartan—Oedema—Irinotecan—colon cancer	0.000171	0.00219	CcSEcCtD
Telmisartan—Myalgia—Fluorouracil—colon cancer	0.000171	0.00219	CcSEcCtD
Telmisartan—Chest pain—Fluorouracil—colon cancer	0.000171	0.00219	CcSEcCtD
Telmisartan—Infection—Irinotecan—colon cancer	0.00017	0.00218	CcSEcCtD
Telmisartan—Hyperhidrosis—Vincristine—colon cancer	0.00017	0.00218	CcSEcCtD
Telmisartan—Hepatobiliary disease—Capecitabine—colon cancer	0.00017	0.00218	CcSEcCtD
Telmisartan—Epistaxis—Capecitabine—colon cancer	0.00017	0.00217	CcSEcCtD
Telmisartan—Discomfort—Fluorouracil—colon cancer	0.000169	0.00216	CcSEcCtD
Telmisartan—Shock—Irinotecan—colon cancer	0.000169	0.00216	CcSEcCtD
Telmisartan—Nervous system disorder—Irinotecan—colon cancer	0.000168	0.00215	CcSEcCtD
Telmisartan—Thrombocytopenia—Irinotecan—colon cancer	0.000168	0.00215	CcSEcCtD
Telmisartan—Anorexia—Vincristine—colon cancer	0.000168	0.00215	CcSEcCtD
Telmisartan—ABCB1—liver—colon cancer	0.000166	0.00438	CbGeAlD
Telmisartan—Hyperhidrosis—Irinotecan—colon cancer	0.000166	0.00212	CcSEcCtD
Telmisartan—Hypotension—Vincristine—colon cancer	0.000164	0.0021	CcSEcCtD
Telmisartan—Bradycardia—Capecitabine—colon cancer	0.000164	0.0021	CcSEcCtD
Telmisartan—Oedema—Fluorouracil—colon cancer	0.000164	0.0021	CcSEcCtD
Telmisartan—Anaphylactic shock—Fluorouracil—colon cancer	0.000164	0.0021	CcSEcCtD
Telmisartan—Anorexia—Irinotecan—colon cancer	0.000163	0.00209	CcSEcCtD
Telmisartan—Infection—Fluorouracil—colon cancer	0.000163	0.00209	CcSEcCtD
Telmisartan—Rhinitis—Capecitabine—colon cancer	0.000162	0.00207	CcSEcCtD
Telmisartan—Nervous system disorder—Fluorouracil—colon cancer	0.000161	0.00206	CcSEcCtD
Telmisartan—Thrombocytopenia—Fluorouracil—colon cancer	0.000161	0.00206	CcSEcCtD
Telmisartan—Hypoaesthesia—Capecitabine—colon cancer	0.000161	0.00205	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Vincristine—colon cancer	0.00016	0.00205	CcSEcCtD
Telmisartan—Pharyngitis—Capecitabine—colon cancer	0.00016	0.00205	CcSEcCtD
Telmisartan—Tachycardia—Fluorouracil—colon cancer	0.00016	0.00205	CcSEcCtD
Telmisartan—Hypotension—Irinotecan—colon cancer	0.00016	0.00205	CcSEcCtD
Telmisartan—Urinary tract disorder—Capecitabine—colon cancer	0.000159	0.00204	CcSEcCtD
Telmisartan—Insomnia—Vincristine—colon cancer	0.000159	0.00204	CcSEcCtD
Telmisartan—Oedema peripheral—Capecitabine—colon cancer	0.000159	0.00203	CcSEcCtD
Telmisartan—ABCG2—Fluoropyrimidine Activity—TYMS—colon cancer	0.000159	0.0149	CbGpPWpGaD
Telmisartan—Connective tissue disorder—Capecitabine—colon cancer	0.000159	0.00203	CcSEcCtD
Telmisartan—Urethral disorder—Capecitabine—colon cancer	0.000158	0.00202	CcSEcCtD
Telmisartan—Paraesthesia—Vincristine—colon cancer	0.000158	0.00202	CcSEcCtD
Telmisartan—Breast disorder—Methotrexate—colon cancer	0.000157	0.00201	CcSEcCtD
Telmisartan—Anorexia—Fluorouracil—colon cancer	0.000156	0.002	CcSEcCtD
Telmisartan—Visual impairment—Capecitabine—colon cancer	0.000156	0.00199	CcSEcCtD
Telmisartan—Insomnia—Irinotecan—colon cancer	0.000155	0.00198	CcSEcCtD
Telmisartan—Paraesthesia—Irinotecan—colon cancer	0.000154	0.00197	CcSEcCtD
Telmisartan—Hypotension—Fluorouracil—colon cancer	0.000153	0.00196	CcSEcCtD
Telmisartan—Decreased appetite—Vincristine—colon cancer	0.000153	0.00196	CcSEcCtD
Telmisartan—Dyspnoea—Irinotecan—colon cancer	0.000153	0.00195	CcSEcCtD
Telmisartan—Somnolence—Irinotecan—colon cancer	0.000152	0.00195	CcSEcCtD
Telmisartan—Losartan—ABCB1—colon cancer	0.000152	0.392	CrCbGaD
Telmisartan—Gastrointestinal disorder—Vincristine—colon cancer	0.000152	0.00194	CcSEcCtD
Telmisartan—Fatigue—Vincristine—colon cancer	0.000152	0.00194	CcSEcCtD
Telmisartan—Eye disorder—Capecitabine—colon cancer	0.000151	0.00193	CcSEcCtD
Telmisartan—Dyspepsia—Irinotecan—colon cancer	0.000151	0.00193	CcSEcCtD
Telmisartan—Tinnitus—Capecitabine—colon cancer	0.000151	0.00193	CcSEcCtD
Telmisartan—Constipation—Vincristine—colon cancer	0.000151	0.00192	CcSEcCtD
Telmisartan—Pain—Vincristine—colon cancer	0.000151	0.00192	CcSEcCtD
Telmisartan—Asthma—Methotrexate—colon cancer	0.00015	0.00192	CcSEcCtD
Telmisartan—Cardiac disorder—Capecitabine—colon cancer	0.00015	0.00192	CcSEcCtD
Telmisartan—Flushing—Capecitabine—colon cancer	0.00015	0.00192	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00015	0.00191	CcSEcCtD
Telmisartan—AGTR1—Arf6 trafficking events—CDH1—colon cancer	0.000149	0.014	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—HNF4A—colon cancer	0.000149	0.014	CbGpPWpGaD
Telmisartan—Decreased appetite—Irinotecan—colon cancer	0.000149	0.00191	CcSEcCtD
Telmisartan—Eosinophilia—Methotrexate—colon cancer	0.000149	0.0019	CcSEcCtD
Telmisartan—Insomnia—Fluorouracil—colon cancer	0.000148	0.0019	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—ABCB1—colon cancer	0.000148	0.0139	CbGpPWpGaD
Telmisartan—Gastrointestinal disorder—Irinotecan—colon cancer	0.000148	0.00189	CcSEcCtD
Telmisartan—Fatigue—Irinotecan—colon cancer	0.000148	0.00189	CcSEcCtD
Telmisartan—Paraesthesia—Fluorouracil—colon cancer	0.000147	0.00189	CcSEcCtD
Telmisartan—Constipation—Irinotecan—colon cancer	0.000147	0.00187	CcSEcCtD
Telmisartan—Pain—Irinotecan—colon cancer	0.000147	0.00187	CcSEcCtD
Telmisartan—Angiopathy—Capecitabine—colon cancer	0.000147	0.00187	CcSEcCtD
Telmisartan—Dyspnoea—Fluorouracil—colon cancer	0.000146	0.00187	CcSEcCtD
Telmisartan—PPARG—Circadian rythm related genes—TOP1—colon cancer	0.000146	0.0137	CbGpPWpGaD
Telmisartan—Somnolence—Fluorouracil—colon cancer	0.000146	0.00187	CcSEcCtD
Telmisartan—Immune system disorder—Capecitabine—colon cancer	0.000146	0.00187	CcSEcCtD
Telmisartan—Mediastinal disorder—Capecitabine—colon cancer	0.000146	0.00186	CcSEcCtD
Telmisartan—Chills—Capecitabine—colon cancer	0.000145	0.00185	CcSEcCtD
Telmisartan—Dyspepsia—Fluorouracil—colon cancer	0.000145	0.00185	CcSEcCtD
Telmisartan—Arrhythmia—Capecitabine—colon cancer	0.000144	0.00184	CcSEcCtD
Telmisartan—Abdominal discomfort—Methotrexate—colon cancer	0.000144	0.00184	CcSEcCtD
Telmisartan—Gastrointestinal pain—Vincristine—colon cancer	0.000144	0.00184	CcSEcCtD
Telmisartan—Decreased appetite—Fluorouracil—colon cancer	0.000143	0.00183	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000142	0.00181	CcSEcCtD
Telmisartan—Mental disorder—Capecitabine—colon cancer	0.000141	0.00181	CcSEcCtD
Telmisartan—Feeling abnormal—Irinotecan—colon cancer	0.000141	0.00181	CcSEcCtD
Telmisartan—Malnutrition—Capecitabine—colon cancer	0.000141	0.0018	CcSEcCtD
Telmisartan—Erythema—Capecitabine—colon cancer	0.000141	0.0018	CcSEcCtD
Telmisartan—Dysuria—Methotrexate—colon cancer	0.00014	0.0018	CcSEcCtD
Telmisartan—Pain—Fluorouracil—colon cancer	0.00014	0.0018	CcSEcCtD
Telmisartan—Gastrointestinal pain—Irinotecan—colon cancer	0.00014	0.00179	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Methotrexate—colon cancer	0.00014	0.00178	CcSEcCtD
Telmisartan—Body temperature increased—Vincristine—colon cancer	0.000139	0.00178	CcSEcCtD
Telmisartan—Abdominal pain—Vincristine—colon cancer	0.000139	0.00178	CcSEcCtD
Telmisartan—Flatulence—Capecitabine—colon cancer	0.000139	0.00177	CcSEcCtD
Telmisartan—Erectile dysfunction—Methotrexate—colon cancer	0.000138	0.00177	CcSEcCtD
Telmisartan—Dysgeusia—Capecitabine—colon cancer	0.000138	0.00176	CcSEcCtD
Telmisartan—Back pain—Capecitabine—colon cancer	0.000136	0.00174	CcSEcCtD
Telmisartan—Body temperature increased—Irinotecan—colon cancer	0.000135	0.00173	CcSEcCtD
Telmisartan—Abdominal pain—Irinotecan—colon cancer	0.000135	0.00173	CcSEcCtD
Telmisartan—Feeling abnormal—Fluorouracil—colon cancer	0.000135	0.00173	CcSEcCtD
Telmisartan—Muscle spasms—Capecitabine—colon cancer	0.000135	0.00173	CcSEcCtD
Telmisartan—Pneumonia—Methotrexate—colon cancer	0.000135	0.00172	CcSEcCtD
Telmisartan—Infestation NOS—Methotrexate—colon cancer	0.000134	0.00171	CcSEcCtD
Telmisartan—Infestation—Methotrexate—colon cancer	0.000134	0.00171	CcSEcCtD
Telmisartan—Depression—Methotrexate—colon cancer	0.000134	0.00171	CcSEcCtD
Telmisartan—Renal failure—Methotrexate—colon cancer	0.000132	0.00168	CcSEcCtD
Telmisartan—Ill-defined disorder—Capecitabine—colon cancer	0.00013	0.00167	CcSEcCtD
Telmisartan—Urticaria—Fluorouracil—colon cancer	0.00013	0.00167	CcSEcCtD
Telmisartan—Conjunctivitis—Methotrexate—colon cancer	0.00013	0.00166	CcSEcCtD
Telmisartan—Anaemia—Capecitabine—colon cancer	0.00013	0.00166	CcSEcCtD
Telmisartan—Body temperature increased—Fluorouracil—colon cancer	0.00013	0.00166	CcSEcCtD
Telmisartan—Hypersensitivity—Vincristine—colon cancer	0.00013	0.00166	CcSEcCtD
Telmisartan—Haematuria—Methotrexate—colon cancer	0.000128	0.00163	CcSEcCtD
Telmisartan—ABCB1—lymph node—colon cancer	0.000127	0.00336	CbGeAlD
Telmisartan—Malaise—Capecitabine—colon cancer	0.000127	0.00162	CcSEcCtD
Telmisartan—Hepatobiliary disease—Methotrexate—colon cancer	0.000127	0.00162	CcSEcCtD
Telmisartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000127	0.0119	CbGpPWpGaD
Telmisartan—Epistaxis—Methotrexate—colon cancer	0.000126	0.00162	CcSEcCtD
Telmisartan—Vertigo—Capecitabine—colon cancer	0.000126	0.00162	CcSEcCtD
Telmisartan—Hypersensitivity—Irinotecan—colon cancer	0.000126	0.00161	CcSEcCtD
Telmisartan—Asthenia—Vincristine—colon cancer	0.000126	0.00161	CcSEcCtD
Telmisartan—Syncope—Capecitabine—colon cancer	0.000126	0.00161	CcSEcCtD
Telmisartan—AGTR1—Arf6 signaling events—SRC—colon cancer	0.000126	0.0118	CbGpPWpGaD
Telmisartan—Palpitations—Capecitabine—colon cancer	0.000124	0.00159	CcSEcCtD
Telmisartan—Loss of consciousness—Capecitabine—colon cancer	0.000124	0.00158	CcSEcCtD
Telmisartan—Asthenia—Irinotecan—colon cancer	0.000123	0.00157	CcSEcCtD
Telmisartan—Cough—Capecitabine—colon cancer	0.000123	0.00157	CcSEcCtD
Telmisartan—Hypertension—Capecitabine—colon cancer	0.000121	0.00155	CcSEcCtD
Telmisartan—Hypersensitivity—Fluorouracil—colon cancer	0.000121	0.00155	CcSEcCtD
Telmisartan—Diarrhoea—Vincristine—colon cancer	0.00012	0.00154	CcSEcCtD
Telmisartan—Myalgia—Capecitabine—colon cancer	0.00012	0.00153	CcSEcCtD
Telmisartan—Chest pain—Capecitabine—colon cancer	0.00012	0.00153	CcSEcCtD
Telmisartan—Arthralgia—Capecitabine—colon cancer	0.00012	0.00153	CcSEcCtD
Telmisartan—Pharyngitis—Methotrexate—colon cancer	0.000119	0.00153	CcSEcCtD
Telmisartan—Anxiety—Capecitabine—colon cancer	0.000119	0.00153	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000119	0.00152	CcSEcCtD
Telmisartan—Urinary tract disorder—Methotrexate—colon cancer	0.000119	0.00152	CcSEcCtD
Telmisartan—Discomfort—Capecitabine—colon cancer	0.000118	0.00151	CcSEcCtD
Telmisartan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—colon cancer	0.000118	0.0111	CbGpPWpGaD
Telmisartan—Urethral disorder—Methotrexate—colon cancer	0.000118	0.00151	CcSEcCtD
Telmisartan—Diarrhoea—Irinotecan—colon cancer	0.000117	0.0015	CcSEcCtD
Telmisartan—Dry mouth—Capecitabine—colon cancer	0.000117	0.0015	CcSEcCtD
Telmisartan—Dizziness—Vincristine—colon cancer	0.000116	0.00149	CcSEcCtD
Telmisartan—Pruritus—Fluorouracil—colon cancer	0.000116	0.00149	CcSEcCtD
Telmisartan—Visual impairment—Methotrexate—colon cancer	0.000116	0.00148	CcSEcCtD
Telmisartan—Oedema—Capecitabine—colon cancer	0.000115	0.00147	CcSEcCtD
Telmisartan—Infection—Capecitabine—colon cancer	0.000114	0.00146	CcSEcCtD
Telmisartan—Dizziness—Irinotecan—colon cancer	0.000113	0.00145	CcSEcCtD
Telmisartan—Shock—Capecitabine—colon cancer	0.000113	0.00144	CcSEcCtD
Telmisartan—Nervous system disorder—Capecitabine—colon cancer	0.000113	0.00144	CcSEcCtD
Telmisartan—Eye disorder—Methotrexate—colon cancer	0.000112	0.00144	CcSEcCtD
Telmisartan—Diarrhoea—Fluorouracil—colon cancer	0.000112	0.00144	CcSEcCtD
Telmisartan—Thrombocytopenia—Capecitabine—colon cancer	0.000112	0.00144	CcSEcCtD
Telmisartan—Tinnitus—Methotrexate—colon cancer	0.000112	0.00143	CcSEcCtD
Telmisartan—Tachycardia—Capecitabine—colon cancer	0.000112	0.00143	CcSEcCtD
Telmisartan—Vomiting—Vincristine—colon cancer	0.000112	0.00143	CcSEcCtD
Telmisartan—Cardiac disorder—Methotrexate—colon cancer	0.000112	0.00143	CcSEcCtD
Telmisartan—Skin disorder—Capecitabine—colon cancer	0.000111	0.00143	CcSEcCtD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—APC—colon cancer	0.000111	0.0104	CbGpPWpGaD
Telmisartan—Rash—Vincristine—colon cancer	0.000111	0.00142	CcSEcCtD
Telmisartan—Hyperhidrosis—Capecitabine—colon cancer	0.000111	0.00142	CcSEcCtD
Telmisartan—Dermatitis—Vincristine—colon cancer	0.000111	0.00142	CcSEcCtD
Telmisartan—AGTR1—Arf6 signaling events—EGFR—colon cancer	0.00011	0.0104	CbGpPWpGaD
Telmisartan—Headache—Vincristine—colon cancer	0.00011	0.00141	CcSEcCtD
Telmisartan—AGTR1—Arf6 trafficking events—CTNNB1—colon cancer	0.00011	0.0103	CbGpPWpGaD
Telmisartan—Anorexia—Capecitabine—colon cancer	0.000109	0.0014	CcSEcCtD
Telmisartan—Angiopathy—Methotrexate—colon cancer	0.000109	0.00139	CcSEcCtD
Telmisartan—Vomiting—Irinotecan—colon cancer	0.000109	0.00139	CcSEcCtD
Telmisartan—Immune system disorder—Methotrexate—colon cancer	0.000109	0.00139	CcSEcCtD
Telmisartan—Dizziness—Fluorouracil—colon cancer	0.000109	0.00139	CcSEcCtD
Telmisartan—Mediastinal disorder—Methotrexate—colon cancer	0.000108	0.00139	CcSEcCtD
Telmisartan—Rash—Irinotecan—colon cancer	0.000108	0.00138	CcSEcCtD
Telmisartan—Dermatitis—Irinotecan—colon cancer	0.000108	0.00138	CcSEcCtD
Telmisartan—Chills—Methotrexate—colon cancer	0.000108	0.00138	CcSEcCtD
Telmisartan—Headache—Irinotecan—colon cancer	0.000107	0.00137	CcSEcCtD
Telmisartan—Hypotension—Capecitabine—colon cancer	0.000107	0.00137	CcSEcCtD
Telmisartan—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	0.000106	0.00998	CbGpPWpGaD
Telmisartan—Mental disorder—Methotrexate—colon cancer	0.000105	0.00135	CcSEcCtD
Telmisartan—Erythema—Methotrexate—colon cancer	0.000105	0.00134	CcSEcCtD
Telmisartan—Malnutrition—Methotrexate—colon cancer	0.000105	0.00134	CcSEcCtD
Telmisartan—Nausea—Vincristine—colon cancer	0.000105	0.00134	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000105	0.00134	CcSEcCtD
Telmisartan—Vomiting—Fluorouracil—colon cancer	0.000104	0.00133	CcSEcCtD
Telmisartan—Insomnia—Capecitabine—colon cancer	0.000104	0.00133	CcSEcCtD
Telmisartan—Rash—Fluorouracil—colon cancer	0.000104	0.00132	CcSEcCtD
Telmisartan—Dermatitis—Fluorouracil—colon cancer	0.000103	0.00132	CcSEcCtD
Telmisartan—Paraesthesia—Capecitabine—colon cancer	0.000103	0.00132	CcSEcCtD
Telmisartan—Headache—Fluorouracil—colon cancer	0.000103	0.00132	CcSEcCtD
Telmisartan—Dysgeusia—Methotrexate—colon cancer	0.000102	0.00131	CcSEcCtD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—colon cancer	0.000102	0.0096	CbGpPWpGaD
Telmisartan—Dyspnoea—Capecitabine—colon cancer	0.000102	0.00131	CcSEcCtD
Telmisartan—Nausea—Irinotecan—colon cancer	0.000102	0.0013	CcSEcCtD
Telmisartan—Back pain—Methotrexate—colon cancer	0.000101	0.00129	CcSEcCtD
Telmisartan—Dyspepsia—Capecitabine—colon cancer	0.000101	0.00129	CcSEcCtD
Telmisartan—Decreased appetite—Capecitabine—colon cancer	9.97e-05	0.00128	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Capecitabine—colon cancer	9.9e-05	0.00127	CcSEcCtD
Telmisartan—Fatigue—Capecitabine—colon cancer	9.89e-05	0.00126	CcSEcCtD
Telmisartan—Constipation—Capecitabine—colon cancer	9.81e-05	0.00125	CcSEcCtD
Telmisartan—Pain—Capecitabine—colon cancer	9.81e-05	0.00125	CcSEcCtD
Telmisartan—Nausea—Fluorouracil—colon cancer	9.75e-05	0.00125	CcSEcCtD
Telmisartan—Ill-defined disorder—Methotrexate—colon cancer	9.71e-05	0.00124	CcSEcCtD
Telmisartan—Anaemia—Methotrexate—colon cancer	9.67e-05	0.00124	CcSEcCtD
Telmisartan—Feeling abnormal—Capecitabine—colon cancer	9.45e-05	0.00121	CcSEcCtD
Telmisartan—Malaise—Methotrexate—colon cancer	9.44e-05	0.00121	CcSEcCtD
Telmisartan—Vertigo—Methotrexate—colon cancer	9.4e-05	0.0012	CcSEcCtD
Telmisartan—Gastrointestinal pain—Capecitabine—colon cancer	9.38e-05	0.0012	CcSEcCtD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—ABCB1—colon cancer	9.3e-05	0.00873	CbGpPWpGaD
Telmisartan—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	9.19e-05	0.00863	CbGpPWpGaD
Telmisartan—Cough—Methotrexate—colon cancer	9.13e-05	0.00117	CcSEcCtD
Telmisartan—Urticaria—Capecitabine—colon cancer	9.11e-05	0.00117	CcSEcCtD
Telmisartan—Abdominal pain—Capecitabine—colon cancer	9.07e-05	0.00116	CcSEcCtD
Telmisartan—Body temperature increased—Capecitabine—colon cancer	9.07e-05	0.00116	CcSEcCtD
Telmisartan—CYP2C19—Metapathway biotransformation—CHST5—colon cancer	8.94e-05	0.00838	CbGpPWpGaD
Telmisartan—Arthralgia—Methotrexate—colon cancer	8.91e-05	0.00114	CcSEcCtD
Telmisartan—Chest pain—Methotrexate—colon cancer	8.91e-05	0.00114	CcSEcCtD
Telmisartan—Myalgia—Methotrexate—colon cancer	8.91e-05	0.00114	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	8.85e-05	0.00113	CcSEcCtD
Telmisartan—Discomfort—Methotrexate—colon cancer	8.8e-05	0.00113	CcSEcCtD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—colon cancer	8.72e-05	0.00818	CbGpPWpGaD
Telmisartan—Anaphylactic shock—Methotrexate—colon cancer	8.54e-05	0.00109	CcSEcCtD
Telmisartan—Infection—Methotrexate—colon cancer	8.48e-05	0.00108	CcSEcCtD
Telmisartan—Hypersensitivity—Capecitabine—colon cancer	8.45e-05	0.00108	CcSEcCtD
Telmisartan—Nervous system disorder—Methotrexate—colon cancer	8.37e-05	0.00107	CcSEcCtD
Telmisartan—Thrombocytopenia—Methotrexate—colon cancer	8.36e-05	0.00107	CcSEcCtD
Telmisartan—Skin disorder—Methotrexate—colon cancer	8.3e-05	0.00106	CcSEcCtD
Telmisartan—Hyperhidrosis—Methotrexate—colon cancer	8.26e-05	0.00106	CcSEcCtD
Telmisartan—Asthenia—Capecitabine—colon cancer	8.23e-05	0.00105	CcSEcCtD
Telmisartan—Anorexia—Methotrexate—colon cancer	8.14e-05	0.00104	CcSEcCtD
Telmisartan—Pruritus—Capecitabine—colon cancer	8.12e-05	0.00104	CcSEcCtD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—colon cancer	8.09e-05	0.00759	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—HNF4A—colon cancer	8.06e-05	0.00756	CbGpPWpGaD
Telmisartan—Hypotension—Methotrexate—colon cancer	7.98e-05	0.00102	CcSEcCtD
Telmisartan—Diarrhoea—Capecitabine—colon cancer	7.85e-05	0.001	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Methotrexate—colon cancer	7.78e-05	0.000995	CcSEcCtD
Telmisartan—Insomnia—Methotrexate—colon cancer	7.72e-05	0.000988	CcSEcCtD
Telmisartan—Paraesthesia—Methotrexate—colon cancer	7.67e-05	0.000981	CcSEcCtD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—CCND1—colon cancer	7.63e-05	0.00716	CbGpPWpGaD
Telmisartan—Dyspnoea—Methotrexate—colon cancer	7.61e-05	0.000974	CcSEcCtD
Telmisartan—Somnolence—Methotrexate—colon cancer	7.59e-05	0.000971	CcSEcCtD
Telmisartan—Dizziness—Capecitabine—colon cancer	7.59e-05	0.00097	CcSEcCtD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—CTNNB1—colon cancer	7.56e-05	0.00709	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—CASP3—colon cancer	7.54e-05	0.00707	CbGpPWpGaD
Telmisartan—Dyspepsia—Methotrexate—colon cancer	7.52e-05	0.000961	CcSEcCtD
Telmisartan—Decreased appetite—Methotrexate—colon cancer	7.42e-05	0.000949	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—CA7—colon cancer	7.42e-05	0.00696	CbGpPWpGaD
Telmisartan—Gastrointestinal disorder—Methotrexate—colon cancer	7.37e-05	0.000943	CcSEcCtD
Telmisartan—Fatigue—Methotrexate—colon cancer	7.36e-05	0.000942	CcSEcCtD
Telmisartan—Pain—Methotrexate—colon cancer	7.3e-05	0.000934	CcSEcCtD
Telmisartan—Vomiting—Capecitabine—colon cancer	7.29e-05	0.000933	CcSEcCtD
Telmisartan—Rash—Capecitabine—colon cancer	7.23e-05	0.000925	CcSEcCtD
Telmisartan—Dermatitis—Capecitabine—colon cancer	7.23e-05	0.000924	CcSEcCtD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—colon cancer	7.2e-05	0.00676	CbGpPWpGaD
Telmisartan—ABCG2—HIF-2-alpha transcription factor network—EP300—colon cancer	7.2e-05	0.00675	CbGpPWpGaD
Telmisartan—Headache—Capecitabine—colon cancer	7.19e-05	0.000919	CcSEcCtD
Telmisartan—Feeling abnormal—Methotrexate—colon cancer	7.04e-05	0.0009	CcSEcCtD
Telmisartan—Gastrointestinal pain—Methotrexate—colon cancer	6.98e-05	0.000893	CcSEcCtD
Telmisartan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—colon cancer	6.82e-05	0.0064	CbGpPWpGaD
Telmisartan—Nausea—Capecitabine—colon cancer	6.81e-05	0.000871	CcSEcCtD
Telmisartan—Urticaria—Methotrexate—colon cancer	6.78e-05	0.000868	CcSEcCtD
Telmisartan—Body temperature increased—Methotrexate—colon cancer	6.75e-05	0.000863	CcSEcCtD
Telmisartan—Abdominal pain—Methotrexate—colon cancer	6.75e-05	0.000863	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—VEGFA—colon cancer	6.4e-05	0.006	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CA7—colon cancer	6.33e-05	0.00594	CbGpPWpGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—CCND1—colon cancer	6.31e-05	0.00592	CbGpPWpGaD
Telmisartan—Hypersensitivity—Methotrexate—colon cancer	6.29e-05	0.000805	CcSEcCtD
Telmisartan—Asthenia—Methotrexate—colon cancer	6.13e-05	0.000784	CcSEcCtD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—MYC—colon cancer	6.12e-05	0.00574	CbGpPWpGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—CDKN1A—colon cancer	6.1e-05	0.00573	CbGpPWpGaD
Telmisartan—Pruritus—Methotrexate—colon cancer	6.04e-05	0.000773	CcSEcCtD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	6e-05	0.00563	CbGpPWpGaD
Telmisartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	5.95e-05	0.00558	CbGpPWpGaD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—colon cancer	5.89e-05	0.00552	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—TGFB1—colon cancer	5.87e-05	0.00551	CbGpPWpGaD
Telmisartan—Diarrhoea—Methotrexate—colon cancer	5.84e-05	0.000747	CcSEcCtD
Telmisartan—PPARG—Regulation of retinoblastoma protein—EP300—colon cancer	5.81e-05	0.00545	CbGpPWpGaD
Telmisartan—Dizziness—Methotrexate—colon cancer	5.65e-05	0.000722	CcSEcCtD
Telmisartan—PPARG—Signaling events mediated by HDAC Class I—EP300—colon cancer	5.54e-05	0.0052	CbGpPWpGaD
Telmisartan—Vomiting—Methotrexate—colon cancer	5.43e-05	0.000694	CcSEcCtD
Telmisartan—Rash—Methotrexate—colon cancer	5.38e-05	0.000689	CcSEcCtD
Telmisartan—Dermatitis—Methotrexate—colon cancer	5.38e-05	0.000688	CcSEcCtD
Telmisartan—Headache—Methotrexate—colon cancer	5.35e-05	0.000684	CcSEcCtD
Telmisartan—ABCG2—Fluoropyrimidine Activity—TP53—colon cancer	5.28e-05	0.00495	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—TYMS—colon cancer	5.14e-05	0.00482	CbGpPWpGaD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—EP300—colon cancer	5.13e-05	0.00482	CbGpPWpGaD
Telmisartan—Nausea—Methotrexate—colon cancer	5.07e-05	0.000649	CcSEcCtD
Telmisartan—PPARG—Developmental Biology—DCC—colon cancer	4.85e-05	0.00455	CbGpPWpGaD
Telmisartan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	4.68e-05	0.00439	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CA7—colon cancer	4.62e-05	0.00433	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—DLC1—colon cancer	4.58e-05	0.0043	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CHST5—colon cancer	4.5e-05	0.00422	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ODC1—colon cancer	4.5e-05	0.00422	CbGpPWpGaD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—colon cancer	4.46e-05	0.00419	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—HNF4A—colon cancer	4.34e-05	0.00407	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—LGR5—colon cancer	4.31e-05	0.00404	CbGpPWpGaD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—AKT1—colon cancer	4.25e-05	0.00398	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—EP300—colon cancer	4.23e-05	0.00397	CbGpPWpGaD
Telmisartan—PPARG—SREBP signalling—PIK3CA—colon cancer	4.15e-05	0.00389	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	4.09e-05	0.00384	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—HNF4A—colon cancer	4.08e-05	0.00383	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—colon cancer	4.01e-05	0.00376	CbGpPWpGaD
Telmisartan—PPARG—PPARA activates gene expression—EP300—colon cancer	3.86e-05	0.00362	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ODC1—colon cancer	3.84e-05	0.0036	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CHST5—colon cancer	3.84e-05	0.0036	CbGpPWpGaD
Telmisartan—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	3.78e-05	0.00354	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—CTNNB1—colon cancer	3.63e-05	0.00341	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—CDKN1A—colon cancer	3.55e-05	0.00333	CbGpPWpGaD
Telmisartan—CYP2C19—Arachidonic acid metabolism—PTGS2—colon cancer	3.52e-05	0.0033	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	3.44e-05	0.00323	CbGpPWpGaD
Telmisartan—PPARG—SREBP signalling—AKT1—colon cancer	3.39e-05	0.00318	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AXIN2—colon cancer	3.1e-05	0.0029	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—TGFB1—colon cancer	2.93e-05	0.00275	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—colon cancer	2.84e-05	0.00266	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ODC1—colon cancer	2.8e-05	0.00262	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CHST5—colon cancer	2.8e-05	0.00262	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	2.75e-05	0.00258	CbGpPWpGaD
Telmisartan—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	2.6e-05	0.00244	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—colon cancer	2.58e-05	0.00242	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	2.56e-05	0.0024	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CA7—colon cancer	2.56e-05	0.0024	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—ABCB1—colon cancer	2.54e-05	0.00238	CbGpPWpGaD
Telmisartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	2.53e-05	0.00237	CbGpPWpGaD
Telmisartan—AGTR1—G alpha (q) signalling events—PIK3CA—colon cancer	2.51e-05	0.00235	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CA7—colon cancer	2.5e-05	0.00234	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—colon cancer	2.44e-05	0.00229	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—EP300—colon cancer	2.38e-05	0.00224	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	2.29e-05	0.00215	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—colon cancer	2.24e-05	0.0021	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—TGFB1—colon cancer	2.24e-05	0.0021	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—CASP3—colon cancer	2.21e-05	0.00208	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	2.17e-05	0.00203	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	2.11e-05	0.00198	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—HNF4A—colon cancer	2.09e-05	0.00196	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—colon cancer	2.08e-05	0.00195	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	2.03e-05	0.00191	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—VEGFA—colon cancer	1.88e-05	0.00176	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.86e-05	0.00174	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	1.81e-05	0.0017	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—TGFB1—colon cancer	1.72e-05	0.00162	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—TP53—colon cancer	1.7e-05	0.0016	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	1.58e-05	0.00148	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CHST5—colon cancer	1.55e-05	0.00145	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ODC1—colon cancer	1.55e-05	0.00145	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	1.55e-05	0.00145	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CHST5—colon cancer	1.51e-05	0.00142	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ODC1—colon cancer	1.51e-05	0.00142	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.46e-05	0.00137	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.38e-05	0.0013	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—CTNNB1—colon cancer	1.25e-05	0.00117	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.25e-05	0.00117	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.21e-05	0.00114	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ABCB1—colon cancer	1.19e-05	0.00111	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.18e-05	0.0011	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—TYMS—colon cancer	1.17e-05	0.00109	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—EP300—colon cancer	1.16e-05	0.00109	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—SRC—colon cancer	1.13e-05	0.00106	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—VEGFA—colon cancer	1.1e-05	0.00103	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.09e-05	0.00102	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—NRAS—colon cancer	1.09e-05	0.00102	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—MYC—colon cancer	1.07e-05	0.00101	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.06e-05	0.000997	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.05e-05	0.000987	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.04e-05	0.000972	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.03e-05	0.000965	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ABCB1—colon cancer	1.01e-05	0.000951	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TGFB1—colon cancer	1.01e-05	0.000946	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—TYMS—colon cancer	9.96e-06	0.000934	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—EGFR—colon cancer	9.89e-06	0.000928	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	9.78e-06	0.000918	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	9.51e-06	0.000893	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—KRAS—colon cancer	9.34e-06	0.000877	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	9.27e-06	0.000869	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.98e-06	0.000843	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FGFR3—colon cancer	8.94e-06	0.000839	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	8.52e-06	0.0008	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	8.5e-06	0.000798	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	8.34e-06	0.000782	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PPARG—colon cancer	8.27e-06	0.000776	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—APC—colon cancer	8.21e-06	0.00077	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—NRAS—colon cancer	8.21e-06	0.00077	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—HRAS—colon cancer	7.94e-06	0.000745	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	7.88e-06	0.000739	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—BRAF—colon cancer	7.72e-06	0.000724	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.67e-06	0.000719	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—EGFR—colon cancer	7.48e-06	0.000702	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ABCB1—colon cancer	7.39e-06	0.000694	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—TYMS—colon cancer	7.26e-06	0.000681	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	7.24e-06	0.000679	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CA—colon cancer	7.15e-06	0.000671	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—KRAS—colon cancer	7.06e-06	0.000663	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—AKT1—colon cancer	7.01e-06	0.000658	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	7e-06	0.000657	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS2—colon cancer	6.5e-06	0.00061	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CA—colon cancer	6.49e-06	0.000609	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.4e-06	0.0006	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—HRAS—colon cancer	6.01e-06	0.000563	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	5.91e-06	0.000555	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AKT1—colon cancer	5.84e-06	0.000548	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CASP3—colon cancer	5.79e-06	0.000543	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCND1—colon cancer	5.63e-06	0.000528	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CTNNB1—colon cancer	5.58e-06	0.000523	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS2—colon cancer	5.55e-06	0.000521	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN1A—colon cancer	5.45e-06	0.000511	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—EP300—colon cancer	5.41e-06	0.000507	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AKT1—colon cancer	5.3e-06	0.000497	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EP300—colon cancer	5.18e-06	0.000486	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MYC—colon cancer	5.17e-06	0.000485	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PPARG—colon cancer	5.14e-06	0.000483	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SRC—colon cancer	5.04e-06	0.000473	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.03e-06	0.000472	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—colon cancer	4.91e-06	0.000461	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NRAS—colon cancer	4.85e-06	0.000455	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—EP300—colon cancer	4.62e-06	0.000433	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MYC—colon cancer	4.52e-06	0.000424	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TGFB1—colon cancer	4.51e-06	0.000423	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGFR—colon cancer	4.42e-06	0.000414	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.19e-06	0.000393	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KRAS—colon cancer	4.17e-06	0.000392	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ABCB1—colon cancer	4.09e-06	0.000384	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS2—colon cancer	4.05e-06	0.00038	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TYMS—colon cancer	4.02e-06	0.000377	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CA—colon cancer	4e-06	0.000375	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TYMS—colon cancer	3.93e-06	0.000368	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CA—colon cancer	3.83e-06	0.00036	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—colon cancer	3.71e-06	0.000348	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—AKT1—colon cancer	3.59e-06	0.000336	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HRAS—colon cancer	3.55e-06	0.000333	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CA—colon cancer	3.41e-06	0.00032	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—EP300—colon cancer	3.36e-06	0.000316	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKT1—colon cancer	3.27e-06	0.000307	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT1—colon cancer	3.13e-06	0.000294	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.1e-06	0.00029	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPARG—colon cancer	2.85e-06	0.000267	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKT1—colon cancer	2.79e-06	0.000262	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPARG—colon cancer	2.78e-06	0.000261	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CA—colon cancer	2.49e-06	0.000234	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS2—colon cancer	2.24e-06	0.00021	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS2—colon cancer	2.19e-06	0.000205	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKT1—colon cancer	2.03e-06	0.000191	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—EP300—colon cancer	1.86e-06	0.000175	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—EP300—colon cancer	1.82e-06	0.000171	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CA—colon cancer	1.38e-06	0.000129	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CA—colon cancer	1.35e-06	0.000126	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKT1—colon cancer	1.13e-06	0.000106	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKT1—colon cancer	1.1e-06	0.000103	CbGpPWpGaD
